The Cost and Intermediate Cost-Effectiveness of a Randomized Control Trial Delivering U=U Messaging to Increase HIV Testing Among South African Men

By afschroeder • August 11, 2026

Smith PJ, Davey DJ, Schmucker L, Bekker LG, Medina-Marino A, Thirumurthy H, Buttenheim AM, Meyer-Rath G. The Cost and Intermediate Cost-Effectiveness of a Randomized Control Trial Delivering U=U Messaging to Increase HIV Testing Among South African Men. Glob Health Sci Pract. 2026 Aug 10;14(1):e2400143. doi: 10.9745/GHSP-D-24-00143. PMID: 42575676; PMCID: PMC13455848.

Tags: Infectious Diseases, Publications

Mpox in advanced AIDS with concurrent opportunistic infections: periprocedural management challenges

Murdande S, Mishra S, Munoz A, Fox K, D'Assumpcao C. Mpox in advanced AIDS with concurrent opportunistic infections: periprocedural management challenges. Infect Prev Pract. 2026[...]

Mpox seroprevalence among sex workers and men who have sex with men preceding sustained urban outbreak in the Democratic Republic of the Congo

Mukadi PK, Merritt S, Nkuba-Ndaye A, Halbrook M, Anta Y, Bodisa Matamu T, Hasivirwe Vakaniaki E, Mukadi-Bamuleka D, Harrigan RJ, Lunyanga L, Kacita C, Kompany[...]

Mannan immunoassay for diagnosis of invasive mucormycosis: assay development, preclinical testing and evaluation in an animal model

Burnham-Marusich AR, Pandit V, Alkhazraji S, Gu Y, Zayac KR, Wingard JR, Culver EL, Walish JJ, Ibrahim AS, Kozel TR. Mannan immunoassay for diagnosis of[...]